NexgenRx Inc.

NexgenRx Inc.

December 01, 2008 17:31 ET

NexgenRx Announces Completion of Private Placement

TORONTO, ONTARIO--(Marketwire - Dec. 1, 2008) - NEXGENRX INC. ("NexgenRx" or the "Company") (TSX VENTURE:NXG) is pleased to announce the completion of its $750,000 private placement with the issuance of an aggregate of 250,000 common shares at a price of $0.20 per share for gross proceeds of $50,000 (the remaining $700,000 having been previously issued and announced). This private placement was completed on a non-brokered basis and no finders' fees were paid. In accordance with applicable securities laws, the foregoing common shares are subject to a four-month hold period.

About NexgenRx

NexgenRx provides leading-edge fully integrated health benefits solutions. Utilizing state-of-the-art technology, the Company offers administration and adjudication services related to group health benefit plans offered by various organizations for the benefit of their plan members. More information on NexgenRx can be found at

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.

Contact Information

  • NexgenRx Inc.
    Ronald C. Loucks
    President and CEO
    (416) 695-3393 x 801
    (647) 722-2920 (FAX)
    NexgenRx Inc.
    Jeff Dawley
    (416) 695-3393 x 803
    (647) 722-2921 (FAX)